Closely associated-potential exposure and outcome associations

Ended Awarded Last action

Contract number
HHSF22301010T
Awardee
Awarding agency
Obligated
$1,954,662

Award facts

Contract value 100% obligated
$1,954,662.05 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Wellesley Hills, Wellesley, MA 02481, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00008 -$67,534
Other Administrative Action P00007 · Change COR to sara azimi-bolourian $0
Supplemental Agreement for work within scope P00006 · Additional funding for $17,467.00 $17,467
Other Administrative Action 5 $0
Other Administrative Action 4 $0
Other Administrative Action 3 $0
Change Order 2 $0
Change Order 1 · Modification to extend POP task order continuation mini-sentinel cder program for the eval of potential exposure outcome associations $0
Original award $2,004,729

About this award

This is a firm-fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Harvard Pilgrim Health Care Inc.'s Office of Sponsored Programs Division, a non-profit healthcare organization. The $1,954,662.05 contract supports the FDA's Sentinel Initiative for post-market medical product safety surveillance, involving activities such as maintaining and enhancing the Sentinel system. Harvard Pilgrim leverages its expertise in healthcare data analytics, epidemiology, and public health research to provide these specialized services to the FDA. The contract does not have a set-aside designation, likely due to the technical and data-intensive nature of the work. Harvard Pilgrim has received numerous prime contracts and grants from the Department of Health and Human Services agencies, including the Centers for Disease Control and Prevention and National Institutes of Health, to conduct a range of public health and biomedical research studies.

Quick answers

Who was awarded contract HHSF22301010T?

HHSF22301010T was awarded to Harvard Pilgrim Health Care, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 10, 2012.

How much is contract HHSF22301010T worth?

The government has obligated $1,954,662 on HHSF22301010T.

Is contract HHSF22301010T an order under another contract?

Yes. HHSF22301010T is a delivery order under HHSF223200910006I, an indefinite delivery contract.

Was contract HHSF22301010T competed?

The extent of competition for HHSF22301010T was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award